StockWatch
FilingsClustersSectorsCongress

Data sourced from SEC EDGAR. Not financial advice.

Back
TVTX

Travere Therapeutics, Inc.

Data sourced from SEC EDGAR. Not financial advice. Disclaimer | Privacy Policy

Data from SEC EDGAR
Total Filings
36
Market Buys / Sells
0/18
18 other (exercises, taxes, awards)
Insider Sentiment
Net Selling
Insiders are selling more than buying — may indicate profit-taking
Market Buy / Sell Value
Sell$8,337,095.73

Price History

Insider Buy
Insider Sell

Insiders

9 insiders
REED ELIZABETH E
Chief Legal Officer and GC
No activity (last 5 days)
4S8 total
Baynes Roy D.
Director
No activity (last 5 days)
2S7 total
Cline Christopher R.
CHIEF FINANCIAL OFFICER
No activity (last 5 days)
4S5 total
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
No activity (last 5 days)
1S4 total
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER
No activity (last 5 days)
3S4 total
Inrig Jula
CHIEF MEDICAL OFFICER
No activity (last 5 days)
2S3 total
LYONS GARY A
Director
No activity (last 5 days)
1S2 total
Heerma Peter
CHIEF COMMERCIAL OFFICER
No activity (last 5 days)
1S2 total
ROTE WILLIAM E.
Chief Research Officer
No activity (last 5 days)
1 total
DateInsiderTypeSharesPriceValue
Apr 16, 2026Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
3 Exercises, 1 Sell37,227—$1,147,397.89
Apr 16, 2026Baynes Roy D.
Director
5 Exercises, 2 Sells65,500—$1,928,437.50
Apr 16, 2026LYONS GARY A
Director
1 Exercise, 1 Sell16,000—$459,200.00
Apr 15, 2026REED ELIZABETH E
Chief Legal Officer and GC
1 Award, 3 Exercises, 3 Sells101,441—$2,726,097.41
3 Exercises, 1 Sell
Apr 16, 2026
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
37,227 shr$1,147,397.89
5 Exercises, 2 Sells
Apr 16, 2026
Baynes Roy D.
Director
65,500 shr$1,928,437.50
1 Exercise, 1 Sell
Apr 16, 2026
LYONS GARY A
Director
16,000 shr$459,200.00
1 Award, 3 Exercises, 3 Sells
Apr 15, 2026
REED ELIZABETH E
Chief Legal Officer and GC
101,441 shr$2,726,097.41

1–20 of 36 filings

1 / 2